Tandem Diabetes Care, Inc. recalls t:slim X2 Insulin Pump with…
Tandem Diabetes Care, Inc. recalls t:slim X2 Insulin Pump with Interoperable Technology and 1 more
- Published
- 23 Apr 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
t:slim X2 Insulin Pump with Interoperable Technology
Tandem Mobi Insulin Pump with Interoperable Technology
- Brand / company
- Tandem Diabetes Care, Inc.
- Codes / lots
- Software versions 7.9/UDI: 00389152407012 | Software versions 7.9/UDI: 00389152480114
- Distribution
- US: AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NV, NY, OH, PA, TX, UT, VA, WA, WI OUS: N/A
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 23 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.